IDH2 and glioma: Most notably, static and dynamic O-([18F]fluoroethyl)tyrosine]([18F]FET) uptake parameters, as well as [18F]FET radiomics, have been used to distinguish the IDH status in glioma patients, with good diagnostic accuracy in most but not all studies [31,32,33,34,35].